Springer Nature AG & Co. KGaA (SPGDF)
| Market Cap | 4.60B +16.0% |
| Revenue (ttm) | 2.26B +4.3% |
| Net Income | 417.64M +420.8% |
| EPS | 2.10 +420.4% |
| Shares Out | n/a |
| PE Ratio | 11.02 |
| Forward PE | 11.70 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,000 |
| Average Volume | 2,212 |
| Open | 20.80 |
| Previous Close | 17.90 |
| Day's Range | 20.80 - 20.80 |
| 52-Week Range | 0.01 - 24.04 |
| Beta | n/a |
| RSI | 46.37 |
| Earnings Date | May 5, 2026 |
About SPGDF
Springer Nature AG & Co. KGaA, together with its subsidiaries, engages in the publishing business in Germany, the United Kingdom, the United States, and internationally. The company operates through three segments: Research, Education, and Health. It offers journals across various academic disciplines under the Nature Portfolio and Springer brand names; books in print and digital formats across various scientific disciplines, including monographs, textbooks, conference proceedings, handbook series, reference works, and briefs under the Springer... [Read more]
Financial Performance
In 2025, SPGDF's revenue was 1.93 billion, an increase of 4.29% compared to the previous year's 1.85 billion. Earnings were 355.70 million, an increase of 420.79%.
Financial numbers in EUR Financial StatementsNews
Springer Nature AG & Co. KGaA Earnings Call Transcript: Q1 2026
Q1 2026 saw 6% underlying revenue and 9% AOP growth, led by research and open access. Free cash flow rose to EUR 204 million, leverage dropped to 1.5x, and full-year guidance is reiterated. AI tools and new journal launches support continued outperformance.
Springer Nature price target lowered to EUR 31 from EUR 31.50 at JPMorgan
JPMorgan lowered the firm’s price target on Springer Nature (SPGDF) to EUR 31 from EUR 31.50 and keeps an Overweight rating on the shares.
Springer Nature price target raised to EUR 31.50 from EUR 31 at JPMorgan
JPMorgan analyst Daniel Kerven raised the firm’s price target on Springer Nature (SPGDF) to EUR 31.50 from EUR 31 and keeps an Overweight rating on the shares. Published first on
Springer Nature price target raised to EUR 24.30 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Springer Nature (SPGDF) to EUR 24.30 from EUR 23.90 and keeps an Overweight rating on the shares.
Springer Nature price target raised to EUR 31 from EUR 29 at Deutsche Bank
Deutsche Bank analyst Steve Liechti raised the firm’s price target on Springer Nature (SPGDF) to EUR 31 from EUR 29 and keeps a Buy rating on the shares. Published first
Springer Nature AG & Co. KGaA Earnings Call Transcript: Q4 2025
Delivered strong 2025 results with 6% underlying revenue and 9% AOP growth, led by research and open access. 2026 guidance targets 5%-6% revenue growth and further margin expansion, supported by high renewal rates, robust submissions, and ongoing AI-driven efficiencies.
Springer Nature price target lowered to EUR 31 from EUR 31.10 at JPMorgan
JPMorgan lowered the firm’s price target on Springer Nature (SPGDF) to EUR 31 from EUR 31.10 and keeps an Overweight rating on the shares.
Springer Nature price target raised to EUR 31.10 from EUR 30.50 at JPMorgan
JPMorgan analyst Daniel Kerven raised the firm’s price target on Springer Nature (SPGDF) to EUR 31.10 from EUR 30.50 and keeps an Overweight rating on the shares. Published first on